期刊文献+

对比剂肾病的预防进展 被引量:1

下载PDF
导出
摘要 对比剂肾病(contrast—induced nephropathy,CIN),或对比剂诱导的急性肾损伤(contrast—induced acute kidneyinjury,CI-AKI),是碘对比剂使用过程中的严重不良反应,其定义为使用对比剂后排除其他原因引起的急性肾功能损伤.诊断主要依赖血肌酐(SCr)的变化。
作者 叶龙 李晓兰
出处 《现代医药卫生》 2015年第20期3103-3105,共3页 Journal of Modern Medicine & Health
  • 相关文献

参考文献27

  • 1Morcos SK,Thomsen HS,Webb JA. Contrast-media-induced nephrotoxi- city :a consensus report. Contrast Media Safety Committee ,European So- ciety of Urogenital Radiology (ESUR)[J]. Eur Radio1,1999,9 (8) : 1602- 1613.
  • 2McCullough PA. Contrast-induced acute kidney injury[J]. J Am Coll Car- diol,2008,51 (15) : 1419-1428.
  • 3Wong PC, Li Z, Guo J, et al. Pathophysiology of contrast-induced nephro- pathy[J]. lnt J Cardio1,2012,158 (2) : 186-192.
  • 4Mehran R, Aymong ED, Nikolsky E,et al. A simple risk score for predic- tion of contrast-induced nephropathy after percutaneous coronary interven- tion :development and initial validation [J]. J Am Coil Cardio1,2004, 44(7) : 1393-1399.
  • 5Stacul F,van der Molen AJ, Reimer P, et al. Contrast induced nephropa- thy:updated ESUR Contrast Media Safety Committee guidelines [J]. Eur Radiol,2011,21 (12) :2527-2541.
  • 6Thomson KR, Varma DK. Safe use of radiographic contrast media[J]. Aus- tralian Prescriber, 2010,33 ( 1 ) : 19-22.
  • 7Fliser D ,Laville M ,Covic A,et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury :part 1 :definitions, conservative management and contrast-induced nephropathy[J]. Nephrol Dial Transplant, 2012,27 ( 12 ) : 4263 -4272.
  • 8Pannu N ,Wiebe N,Tonelli M,et al. Prophylaxis strategies for contrast- induced nephropathy[J]. JAMA, 2006,295 (23) :2765-2779.
  • 9Andreucci M,Solomon R,Tasanarong A. Side effects of radiographic con- trast media :pathogenesis,risk factors,and prevention [J]. Biomed Res Int, 2014,2014:741018.
  • 10Mueller C. Prevention of contrast-induced nephropathy with volume sup-plementation[J]. Kidney Int Supl, 2006 (100) : S 16-19.

同被引文献16

  • 1薛文鑫,李静,李怡文,张藜莉.强化瑞舒伐他汀对经皮冠脉介入术后对比剂肾病预防效果的Meta分析[J].中国生化药物杂志,2014,34(6):83-86. 被引量:8
  • 2陈灏珠,丁训杰,廖履坦,等.实用内科学[M].北京:人民卫生出版社,2013:1556.
  • 3Sadat U, Usman A, Gillard JH, et al. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials[J]. J Am Coil Cardiol,2013,62(23) :2167-2175.
  • 4Han Y, Zhu G, Han L, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease [ J]. J Am Coil Cardiol,2014,63 ( 1 ) :62-70.
  • 5Nusca A,Melfi R, Patti G, et at. Statin loading before percutaneous coronary intervention:proposed mechanisms and applications [ J ]. Future Cardio1,2010,6 ( 5 ) :579-589.
  • 6Kim MJ, Choi HS, Oh SH, et al. Impact of acute kidney injury" on clinical outcomes after ST elevation acute myocardial infarction [ J ]. Yonsei Med J,2011,52(4) :603-609.
  • 7Han Y, Zhu G, Hart L, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease[ J ]. J Am Coil Cardiol,2014,63 ( 1 ) :62-70.
  • 8Toso A, Maioli M, Leoncini M, et al. Usefulness of atorvastatin ( 80 rag) in prevention of contrast-induced nephropathy in patients with chronic renal disease[J]. Am J Cardiol. ,2010,105:288-292.
  • 9Maioli M, Toso A, Leoncini M, et al. Persistent renal damage after contrast induced acute kidney injury : incidence, evolution, risk factors, and prognosis[ J ]. Circulation ,2012,125 ( 25 ) :3099-3107.
  • 10李华珍,王红,梁文武.冠状动脉介入术导致对比剂肾病危险因素分析[J].中国动脉硬化杂志,2011,19(6):529-532. 被引量:16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部